Change search criteria ↓

Search results

16 projects found matching your search criteria:

  1. 1. Brain cytochrome P450 as a new target for the treatment of neurological and psychiatric diseases. Studies with human neu…

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii PAN

    Call: OPUS 23, Panel: NZ7

  2. 2. The effect of chronic treatment with iasenapine and iloperidone on the expression and activity of cytochrome P450 in the…

    Principal investigator: dr Przemysław Jan Danek

    Instytut Farmakologii PAN

    Call: PRELUDIUM 16, Panel: NZ7

  3. 3. The role of brain glutamatergic system in the neuroendocrine regulation of cytochrome P450 expression and activity in th…

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii PAN

    Call: OPUS 12, Panel: NZ7

  4. 4. Mechanism of interaction between carbon nanoparticles of diamond, graphene oxide and graphite and cytochrome P450 enzyme…

    Principal investigator: Barbara Agnieszka Strojny

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Wydział Nauk o Zwierzętach

    Call: PRELUDIUM 11, Panel: NZ7

  5. 5. The effect of typical and atypical neuroleptics on the expression of cytochrome P450 isoenzymes 1A2 (CYP1A2) and 3A4 (CY…

    Principal investigator: Agnieszka Basińska-Ziobroń

    Instytut Farmakologii PAN

    Call: PRELUDIUM 8, Panel: NZ7

  6. 6. The effect of the novel atypical neuroleptics on the activity and expression of cytochrome P450 isoforms in human liver

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii PAN

    Call: OPUS 6, Panel: NZ7

  7. 7. The significance of the serotonergic innervation of the brain hypothalamus in the regulation of cytochrome P450

    Principal investigator: prof. Władysława Anna Daniel

    Instytut Farmakologii PAN

    Call: OPUS 6, Panel: NZ7

  8. 8. The role of the brain serotonergic system in the expression and activity of liver cytochrome P450.

    Principal investigator: dr Marta Anna Rysz

    Instytut Farmakologii PAN

    Call: PRELUDIUM 4, Panel: NZ7

  9. 9. Studies on the mechanism regulating expression of hormone-dependent cytochromes P450 in the rat liver under conditions o…

    Principal investigator: Rafał Andrzej Skowronek

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Lekarski w Katowicach

    Call: PRELUDIUM 4, Panel: NZ4

  10. 10. Identification of cytochrome P450 isoenzymes involved in the metabolism of levomepromazine in the human

    Principal investigator: dr hab. Jacek Wójcikowski

    Instytut Farmakologii PAN

    Call: OPUS 1, Panel: NZ4

  11. 11. The influence of the serotonergic system on the regulation of liver CYP activity in hepatocellular carcinoma

    Principal investigator: dr Marta Ewa Kot

    Instytut Farmakologii PAN

    Call: SONATA 4, Panel: NZ4

  12. 12. The effect of prolonged treatment with the new antipsychotics brexpiprazole and lumateperone on human liver function usi…

    Principal investigator: dr Przemysław Jan Danek

    Instytut Farmakologii PAN

    Call: OPUS 26, Panel: NZ4

  13. 13. Porphyrazine based catalyst support for biomimetic studies on selected active pharmaceutical ingredients

    Principal investigator: Tomasz Władysław Koczorowski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: PRELUDIUM 9, Panel: NZ7

  14. 14. Changes in the proteome of the filamentous fungus Cunninghamella echinulata during degradation of organic tin compounds

    Principal investigator: Adrian Soboń

    Uniwersytet Łódzki, Wydział Biologii i Ochrony Środowiska

    Call: PRELUDIUM 7, Panel: NZ9

  15. 15. Influence of chlorpyrifos on the activity of enzymes responsible for the vitamin D3 synthesis in skin cells

    Principal investigator: Krzysztof Bogumił Sawicki

    Instytut Medycyny Wsi im. Witolda Chodźki

    Call: PRELUDIUM 5, Panel: NZ7

  16. 16. Evaluation of the synthesis and metabolism modulation of estrogens - breast cancer risk factors by new synthetic resvera…

    Principal investigator: prof. Wanda Maria Baer-Dubowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

    Call: OPUS 3, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski